Saudi Arabia Proteomics Market

Market Overview:

Saudi Arabia proteomics market size reached USD 417.1 Million in 2025. Looking forward, the market is expected to reach USD 825.9 Million by 2034, exhibiting a growth rate (CAGR) of 7.65% during 2026-2034​. The growing demand for personalized medicines, rising need to enhance the sensitivity and specificity of diagnostic tests and improve patient care, and increasing prevalence of numerous chronic diseases represent some of the key factors driving the market.

Access the full market insights report Request Sample

Proteomics involves the analysis of the structure, function, and interactions of proteins through various advanced analytical methods, such as mass spectrometry, gel electrophoresis, and protein microarrays. It can guide the selection of personalized treatment strategies based on the unique protein profiles of individuals. It provides a holistic view of how proteins collaborate to carry out various biological processes. It offers valuable insights into the intricate mechanisms of underlying disease and the functioning of biological systems. It plays a crucial role in the development of genetically modified organisms (GMOs). It allows for the identification of disease-specific biomarkers, enabling early disease detection and diagnosis. It provides insights into the molecular mechanisms of diseases, aiding in the development of targeted therapies. It helps in identifying potential drug targets by understanding the roles of specific proteins in disease pathways. It complements genomics by providing insights into the functional aspects of genes, as proteins execute most cellular functions. It assists in evaluating the impact of environmental factors on organisms and ecosystems. It aids in assessing drug efficacy and safety through the analysis of protein interactions and responses. As it contributes to the monitoring of environmental pollution and ecosystem health, the demand for proteomics is rising in Saudi Arabia.

Saudi Arabia Proteomics Market Trends:

Increasing Investments in Research and Development (R&D) in Biotechnology

The Saudi Arabian market for proteomics is driven by the increased biotechnology R&D investments. Government programs and funding initiatives are supporting the development of cutting-edge research institutions and driving public-private sector collaborations. Saudi Arabia also participated at BIO 2025, the premier biotech convention, showcasing an energetic national pavilion spearheaded by the Ministry of Health and comprising more than 25 public, private, and research organizations, all driven by a strong vision for the future of biotechnology. This significant global event highlights the Kingdom's commitment to boosting biotech innovation and drawing international investment, aligned with the National Biotechnology Strategy initiated by His Royal Highness the Crown Prince. Additionally, this sustained investment is driving the development of proteomics technologies, further enabling protein identification, quantitation, and analysis. Proteomics has become a major research focus for institutions in the nation due to its potential as a key frontier for advances in personalized medicine, diagnostics, and drug design. Moreover, the Saudi Vision 2030 plan places biotechnology and healthcare as priority sectors, which continues to support proteomics growth in the nation. The growing volume of research papers and clinical trials of proteomics is mirroring this ongoing focus, which is catalyzing the demand for proteomic technologies, reagents, and tools.

Growing Prevalence of Chronic Disorders and Healthcare Demand

Rising cases of chronic illnesses like cancer, diabetes, and cardiovascular diseases are primarily driving the Saudi Arabia's proteomics market. The healthcare sector is more and more emphasizing early diagnosis, precision medicine, and tailored therapies, all of which critically depend upon proteomic technologies. Proteomics is being utilized for biomarker identification for the detection of diseases at early stages and disease follow-up monitoring, which is making treatments more effective. Hospitals, diagnostic laboratories, and research centers are continuously implementing sophisticated proteomics devices to achieve enhanced patient care. In addition, the increasing requirement for healthcare services is driving the setup of additional healthcare centers, most of which are incorporating proteomics within their clinical practice. This increasing emphasis on personalized medicine is further driving the demand for proteomics solutions to tackle challenging medical conditions better. For example, in 2025, King Faisal Specialist Hospital & Research Centre (KFSHRC) initiated precision medicine services in its Family Medicine Clinics, with the goal of enhancing preventive care and delivering tailored healthcare founded on each patient’s genetics and lifestyle. This service facilitates the creation of accurate treatment strategies that lead to better health results for individuals and families.

Technological Developments in Proteomics Tools and Techniques

Advances in proteomics techniques and tools are supporting the growth of the market. Advances in mass spectrometry, high-throughput sequencing, and bioinformatics are enhancing the scalability, accuracy, and sensitivity of proteomic analyses. The ongoing development of these technologies is facilitating researchers to process complex proteomes in an efficient and cost-effective manner. Consequently, advanced proteomics instruments are adopted in both clinical and research environments. Incorporating artificial intelligence (AI) and machine learning (ML) in proteomics processes is also facilitating improved interpretation of data, allowing for better identification of proteins and their interactions. This continued development of proteomics technology is opening up new possibilities in many industries, such as pharmaceuticals, agriculture, and healthcare, thereby promoting a more competitive business environment in Saudi Arabia. The IMARC Group predicts that the Saudi Arabia AI market is projected to attain USD 4,018 Million by 2033.

Saudi Arabia Proteomics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for ​2026-2034​. Our report has categorized the market based on analysis type, component type, technology, application, and end user.

Analysis Type Insights:

To get detailed segment analysis of this market Request Sample

• Structural Proteomics
• Functional Proteomics
• Protein Expression Proteomics

The report has provided a detailed breakup and analysis of the market based on the analysis type. This includes structural proteomics, functional proteomics, and protein expression proteomics.

Component Type Insights:

• Core Proteomics Services
• Bioinformatics Software and Related Services

A detailed breakup and analysis of the market based on the component type have also been provided in the report. This includes core proteomics services and bioinformatics software and related services.

Technology Insights:

• Spectroscopy
• Chromatography
• Electrophoresis
• Protein Microarrays
• X-Ray Crystallography
• Surface Plasmon Resonance
• Others

The report has provided a detailed breakup and analysis of the market based on the technology. This includes spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, and others.

Application Insights:

• Protein Expression Profiling
• Proteome Mining
• Post-Translational Modifications

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes protein expression profiling, proteome mining, and post-translational modifications.

End User Insights:

• Clinical Diagnostic Laboratories
• Research Organizations (Drug Discovery)
• Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes clinical diagnostic laboratories, research organizations (drug discovery), and others.

Regional Insights:

To get detailed regional analysis of this market Request Sample

• Northern and Central Region
• Western Region
• Eastern Region
• Southern Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern and Central Region, Western Region, Eastern Region, and Southern Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Saudi Arabia Proteomics Market News:

• November 2024: Bio-Techne Corporation, a world leader in life sciences, offering innovative tools and bioactive reagents for research and clinical diagnostic communities, announced its partnership with Leader Life Sciences. In terms of the agreement, Leader Life Sciences is appointed as a distributor for Bio-Techne's product portfolio in the Gulf Cooperation Council (GCC) countries, namely Bahrain, Oman, Qatar, Saudi Arabia, and United Arab Emirates.
• July 2024: Bertis has commercialized 'MASTOCHECK,' a test for the diagnosis of breast cancer based on protein biomarkers in a small blood sample, and is now expanding its diagnostic scope to pancreatic and ovarian cancers. Bertis is an early cancer diagnosis company that is utilizing biomarkers found from integrating proteomics that study proteins, artificial intelligence (AI), and machine learning (ML)-based bioinformatics technologies. Mastocheck, the global first breast cancer diagnostic solution based on proteomics, has expanded its share since its debut in the Chinese domestic market in 2019 and recently ventured out to Singapore and Saudi Arabia.
• June 2024: SVAX, the pioneer in delivering cutting-edge healthcare solutions, revealed a groundbreaking agreement with Bertis Inc., a trailblazing proteomics firm, to localize proteomics-based testing in oncology in the GCC and Saudi Arabia. The partnership will start with breast cancer, leveraging Bertis Inc.'s innovative MASTOCHECK platform technology for early diagnosis.

Saudi Arabia Proteomics Market Report Coverage:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Saudi Arabia proteomics market from 2020-2034.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Saudi Arabia proteomics market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Saudi Arabia proteomics industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.